amifostine anhydrous has been researched along with Refractory Anemia in 4 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two patients had RAEB, four RA and one RARS." | 2.70 | Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes. ( Bourantas, KL; Christou, L; Kapsali, HD; Panteli, K; Tsiara, SN, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delforge, M | 1 |
| Raets, V | 1 |
| Van Duppen, V | 1 |
| Boogaerts, M | 1 |
| Hofmann, WK | 1 |
| Seipelt, G | 1 |
| Ottmann, OG | 1 |
| Kalina, U | 1 |
| Koschmieder, S | 1 |
| Brücher, J | 1 |
| Frickhofen, N | 1 |
| Klausmann, M | 1 |
| Mitrou, PS | 1 |
| Hoelzer, D | 1 |
| Tsiara, SN | 1 |
| Kapsali, HD | 1 |
| Panteli, K | 1 |
| Christou, L | 1 |
| Bourantas, KL | 1 |
| Viniou, N | 1 |
| Terpos, E | 1 |
| Galanopoulos, A | 1 |
| Kritikou-Griva, E | 1 |
| Akel, S | 1 |
| Michalis, E | 1 |
| Apostolidou, E | 1 |
| Georgiadou, D | 1 |
| Kouraklis, A | 1 |
| Parharidou, A | 1 |
| Kokkini, G | 1 |
| Symeonidis, A | 1 |
| Anagnostopoulos, NI | 1 |
| Christakis, JI | 1 |
| Tasiopoulou, A | 1 |
| Loukopoulos, D | 1 |
| Yataganas, X | 1 |
2 trials available for amifostine anhydrous and Refractory Anemia
| Article | Year |
|---|---|
Preliminary results of amifostine administration in combination with recombinant human erythropoietin in patients with myelodysplastic syndromes.
Topics: Aged; Amifostine; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Blood Transfusion; | 2001 |
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Topics: Aged; Aged, 80 and over; Amifostine; Anemia, Refractory; Bone Marrow Cells; Colony-Forming Units Ass | 2002 |
2 other studies available for amifostine anhydrous and Refractory Anemia
| Article | Year |
|---|---|
Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anemia, Refractory; Antigens, CD34; Cell Division; Cells | 2003 |
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels.
Topics: Aged; Amifostine; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Drug Administration | 2000 |